Skip to main content
SpringerLink
Log in

Hereditary Hemochromatosis

  • Living reference work entry
  • First Online:
Atlas of Genetic Diagnosis and Counseling

Abstract

Hereditary hemochromatosis (HHC; HFE 1) is a common hereditary disorder of iron metabolism and the most common inherited autosomal recessive disorder in Caucasians with a prevalence of 1 in 300 to 1 in 500 individuals. It is characterized by inappropriately high iron absorption resulting in progressive iron overload.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  • Andrews, N. C. (1999). Disorders of iron metabolism. The New England Journal of Medicine, 341, 1986–1995.

    Article  CAS  PubMed  Google Scholar 

  • Assis, R. A., Kay, F. U., Conti, F. M., et al. (2015). The role of magnetic resonance imaging-T2* in the evaluation of iron overload early in hereditary hemochromatosis. A cross sectional study with 159 patients. American Journal of Hematology, 90, 1–7.

    Article  Google Scholar 

  • Bacon, B. R. (1997). Diagnosis and management of hemochromatosis. Gastroenterology, 113, 995–999.

    Article  CAS  PubMed  Google Scholar 

  • Bardou-Jacquet, E., & Brissot, P. (2014). Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE). Hematology/Oncology Clinics of North America, 28, 625–635.

    Article  PubMed  Google Scholar 

  • Barton, J. C. (2013). Hemochromatosis and iron overload: From bench to clinic. American Journal of the Medical Sciences, 346, 403–412.

    Article  PubMed  Google Scholar 

  • Bothwell, T. H., & MacPhail, A. P. (1998). Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects. Seminars in Hematology, 35, 55–71.

    CAS  PubMed  Google Scholar 

  • Brittenham, G. M., Weiss, G., Brissot, P., et al. (2000). Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism. Hematology American Society of Hematology Education Program, 2000 39–50.

    Google Scholar 

  • Camaschella, C., & Piperno, A. (1997). Hereditary hemochromatosis: Recent advances in molecular genetics and clinical management. Haematologica, 82, 77–84.

    CAS  PubMed  Google Scholar 

  • Edwards, C. Q., Griffen, L. M., Goldgar, D., et al. (1988). Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. New England Journal of Medicine, 318, 1355–1362.

    Article  CAS  PubMed  Google Scholar 

  • Ekanayake, D., Roddick, C., & Powell, L. W. (2015). Recent advances in hemochromatosis: A 2015 update. A summary of proceedings of the 2014 conference held under the auspices of Hemochromatosis Australia. Hepatology International, 9, 174–182.

    Article  PubMed  Google Scholar 

  • Farrell, C. P., Parker, C. J., & Phillips, J. D. (2015). Exome sequencing for molecular characterization of non-HFE hereditary hemochromatosis. Blood Cells, Molecules, and Diseases, 55, 101–103.

    Article  CAS  PubMed  Google Scholar 

  • Feder, J. N., Gnirke, A., Thomas, W., et al. (1996). A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399–408.

    Article  CAS  PubMed  Google Scholar 

  • Feldman, A. G., & Whitington, P. F. (2013). Neonatal hemochromatosis. Journal of Clinical and Experimental Hepatology, 3, 313–320.

    Article  PubMed  PubMed Central  Google Scholar 

  • Fleming, R. E., & Sly, W. S. (2002). Mechanisms of iron accumulation in hereditary hemochromatosis. Annual Review of Physiology, 64, 663–680.

    Article  CAS  PubMed  Google Scholar 

  • Hanson, E. H., Imperatore, G., & Burke, W. (2001). HFE gene and hereditary hemochromatosis: A HuGE review. Human genome epidemiology. American Journal of Epidemiology, 154, 193–206.

    Article  CAS  PubMed  Google Scholar 

  • Harrison, S. A., & Bacon, B. R. (2003). Hereditary hemochromatosis: Update for 2003. Journal of Hepatology, 38(Suppl 1), S14–S23.

    Article  PubMed  Google Scholar 

  • Heissat, S., Collardeau-Frachon, S., Baruteau, J., et al. (2015). Neonatal hemochromatosis: Diagnostic work-up based on a series of 56 cases of fetal death and neonatal liver failure. Journal of Pediatrics, 166, 66–73.

    Article  PubMed  Google Scholar 

  • Husar-Memmer, E., Stadlmayr, A., Datz, C., et al. (2014). HFE-related hemochromatosis: an update for the rheumatologist. Current Rheumatoogy Reports, 16, 393–399.

    Article  Google Scholar 

  • Joshi, R., Shvartsman, M., Moran, E., et al. (2015). Functional consequences of transferrin receptor-2 mutations causing hereditary hemochromatosis type 3. Molecular Genetics & Genomic Medicine, 3, 221–232.

    Article  CAS  Google Scholar 

  • Lopriore, E., Mearin, M. L., Oepkesm, D., et al. (2013). Neonatal hemochromatosis: Management, outcome, and prevention. Prenatal Diagnosis, 33, 1221–1225.

    Article  PubMed  Google Scholar 

  • Mclaren, G. D., & Gordeuk, V. R. (2009). Hereditary hemochromatosis: Insights from the hemochromatosis and iron overload screening (HEIRS) study. Hematology American Society of Hematology Education Program, 2009 195–206.

    Google Scholar 

  • Morrison, E. D., Brandhagen, D. J., Phatak, P. D., et al. (2003). Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Annals of Internal Medicine, 138, 627–633.

    Article  CAS  PubMed  Google Scholar 

  • Moyer, T. P., Highsmith, W. E., Smyrk, T. C., et al. (2011). Hereditary hemochromatosis: Laboratory evaluation. Clinica Chimica Acta, 412, 1485–1492.

    Article  CAS  Google Scholar 

  • Nichols, G. M., & Bacon, B. R. (1989). Hereditary hemochromatosis: Pathogenesis and clinical features of a common disease. American Journal of Gastroenterology, 84, 851–862.

    CAS  PubMed  Google Scholar 

  • Niederau, C., Fischer, R., Sonnenberg, A., et al. (1985). Survival and cause of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. The New England Journal of Medicine, 313, 1256–1262.

    Article  CAS  PubMed  Google Scholar 

  • Niederau, C., Fischer, R., Purschel, A., et al. (1996). Long-term survival in patients with hereditary hemochromatosis. Gastroenterology, 110, 1107–1119.

    Article  CAS  PubMed  Google Scholar 

  • Pelusi, C., Gasparini, D. I., Bianchi, N., et al. (2016). Endocrine dysfunction in hereditary hemochromatosis. [Epub ahead of print].

    Google Scholar 

  • Phatak, P. D., & Cappuccio, J. D. (1994). Management of hereditary hemochromatosis. Blood Reviews, 8, 193–198.

    Article  CAS  PubMed  Google Scholar 

  • Phatak, P. D., Guzman, G., Woll, J. E., et al. (1994). Cost-effectiveness of screening for hereditary hemochromatosis. Archives of Internal Medicine, 154, 769–776.

    Article  CAS  PubMed  Google Scholar 

  • Pietrangelo, A. (2006). Haemochromatosis. Biochimica et Biophysica Acta, 1763, 700–710.

    Article  CAS  PubMed  Google Scholar 

  • Pietrangelo, A. (2010). Hereditary hemochromatosis: Pathogenesis, diagnosis, and treatment. Gastroenterology, 139, 393–408.

    Article  PubMed  Google Scholar 

  • Ramrakhiani, S., & Bacon, B. R. (1998). Hemochromatosis: Advances in molecular genetics and clinical diagnosis. Journal of Clinical Gastroenterology, 27, 41–46.

    Article  CAS  PubMed  Google Scholar 

  • Salgia, R. J., & Brown, K. (2015). Diagnosis and management of hereditary hemochromatosis. Clinical Liver Disease, 19, 187–198.

    Article  Google Scholar 

  • Seckington, R., & Powell, L. (2015). HFE-associated hereditary hemochromatosis. GeneReviews. Updated 17 Sept 2015. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1440/

  • Tavill, A. S. (2001). Diagnosis and management of hemochromatosis. Hepatology, 33, 1321–1328.

    Article  CAS  PubMed  Google Scholar 

  • Whitington, P. F., & Hibbard, J. U. (2004). High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet, 364, 1690–1698.

    Article  CAS  PubMed  Google Scholar 

  • Whitington, P. F., & Kelly, S. (2008). Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics, 121, e1615–e1621.

    Article  PubMed  Google Scholar 

  • Whittington, C. A., & Kowdley, K. V. (2002). Review article: Haemochromatosis. Alimentary Pharmacology and Therapeutics, 16, 1963–1975.

    Article  CAS  PubMed  Google Scholar 

  • Yun, S., & Vincelette, N. D. (2015). Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis. Critical Reviews in Oncology/Hematology, 95, 12–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Genetics, Shriners Hospitals for Children, Shreveport, LA, USA

    Harold Chen

  2. Perinatal and Clinical Genetics, Department of Pediatrics, LSU Health Sciences Center, 1501 Kings Highway, Shreveport, LA, 71130, USA

    Harold Chen

Authors
  1. Harold Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harold Chen .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this entry

Cite this entry

Chen, H. (2016). Hereditary Hemochromatosis. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6430-3_116-2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6430-3_116-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-6430-3

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Search

Navigation